Evaluation of New Markers in Type 3 Angioedema
Angio Edema
About this trial
This is an interventional diagnostic trial for Angio Edema
Eligibility Criteria
Inclusion Criteria:
- Population of patients treated within the CHU Brugmann Hospital for an angioedema (and control group of healthy individuals)
Exclusion Criteria:
- None
Sites / Locations
- CHU Brugmann
Arms of the Study
Arm 1
Arm 2
Arm 3
Arm 4
Arm 5
Arm 6
Experimental
Experimental
Experimental
Experimental
Experimental
Other
Type III angioedema
Idiopathic angioedema
Type I or II angioedema
Post IEC (conversion enzyme inhibitors) angioedema
Histaminic angioedema
Control
White angioedema. Positive for Factor XII mutation. No C1-inhibitors anomaly. Not caused by IEC.
White angioedema. Negative for Factor XII mutation. No C1-inhibitors anomaly. Not caused by IEC.
White angioedema. Negative for Factor XII mutation. C1-inhibitors anomaly. Not caused by IEC.
White angioedema. Negative for Factor XII mutation. No C1-inhibitors anomaly. Caused by IEC.
Red angioedema.Negative for Factor XII mutation. No C1-inhibitors anomaly. Not caused by IEC.
Healthy individuals, no angioedema.